ST Humanwell (600079.SH): HW281171 tablets receive drug clinical trial approval notice

Zhitong Finance APP News, ST Renfu (600079.SH) announced that its wholly-owned subsidiary Hubei Biopharmaceutical Industry Technology Research Institute Co., Ltd. (referred to as "Research Institute Co., Ltd.") recently received the Drug Clinical Trial Approval Notice for HW281171 tablets approved and issued by the National Medical Products Administration.